“Underpowered” Trials Unethical Unless In Early Phase Or Meta-Study – JAMA
This article was originally published in The Tan Sheet
Executive Summary
Early-phase "underpowered" clinical trials of drugs can be considered ethical only if designed to guide later pivotal studies, Scott Halpern, University of Pennsylvania School of Medicine, et al., write in the July 17 Journal of the American Medical Association